-Reuters
AstraZeneca – Daiichi Sankyo’s Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
The European Commission has approved AstraZeneca Plc (NASDAQ:AZN) – Daiichi Sankyo’s (OTC:DSKYF) (OTC:DSNKY) Enhertu (trastuzumab deruxtecan) for advanced HER2-positive gastric or gastroesophageal junction…